Tyra Biosciences Inc. (TYRA)

AI Score

Unlock

10.07

0.05 (0.50%)

At close: Apr 24, 2025, 3:59 PM

10.09

0.15%

After-hours: Apr 24, 2025, 04:05 PM EDT

Tyra Biosciences Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Cash & Equivalents	91.97M	103.89M	99.49M	254.37M	58.01M	215.65M	232.41M	241.7M	251.21M	263.21M	275.11M	292.5M	302.18M	312.82M	135.2M	140.64M	15.22M
Short-Term Investments	249.47M	256.24M	274.31M	128.1M	145.46M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	1M	1M	1M	1M	1M	n/a	1M	1M	1M	1M	243K	243K	n/a	243K	n/a
Other Long-Term Assets	8.38M	7.01M	4.69M	4.96M	5.03M	5.34M	866K	4.87M	4.35M	3.87M	5.08M	362K	50K	318K	2.57M	271K	264K
Receivables	n/a	n/a	n/a	1.5M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	6.02M	5.48M	4.78M	1.5M	8.2M	8.98M	8.33M	5.01M	6.08M	4.26M	2.19M	1.53M	1.88M	678K	n/a	n/a	n/a
Total Current Assets	347.46M	365.61M	378.57M	390.78M	211.67M	224.63M	240.75M	246.71M	257.29M	267.47M	277.3M	294.02M	304.06M	313.5M	135.42M	140.83M	15.28M
Property-Plant & Equipment	7.72M	7.97M	8.19M	8.01M	8.15M	7.38M	7.4M	3.47M	3.54M	3.64M	3.74M	3.58M	2.09M	1.91M	1.92M	467K	466K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-505K	n/a	n/a	n/a	n/a
Total Long-Term Assets	16.09M	14.98M	13.89M	13.96M	14.19M	13.73M	9.27M	8.35M	8.89M	8.51M	9.82M	4.95M	2.64M	2.47M	4.5M	981K	730K
Total Assets	363.56M	380.59M	392.46M	404.74M	225.86M	238.36M	250.01M	255.06M	266.18M	275.99M	287.12M	298.97M	306.7M	315.97M	139.92M	141.81M	16.01M
Account Payables	590K	1.17M	1.58M	2.88M	4.66M	2.31M	1.44M	1.28M	1.15M	2.75M	2.34M	1.36M	599K	2.07M	1.88M	841K	664K
Deferred Revenue	n/a	n/a	-383K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	383K	n/a	280K	148K	144K	n/a	140K	127K	123K	119K	202K	135K	n/a	n/a	n/a
Other Current Liabilities	n/a	n/a	5.81M	4.43M	4.99M	5.14M	1.88M	n/a	1.42M	1.34M	1.65M	2.3M	1.33M	1.8M	854K	536K	n/a
Total Current Liabilities	14.59M	12.37M	10.38M	8.72M	15.33M	10.15M	5.41M	3.68M	5.7M	5.49M	5.46M	4.9M	3.62M	4.77M	3.75M	1.53M	1.86M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	3K	11K	20K	29K	46K	77K	108K	139K	169K	226K	261K	303K	367K	434K	157.75M	157.8M	27.79M
Total Long-Term Liabilities	5.81M	5.93M	6.04M	6.15M	6.26M	6.04M	6.04M	2.58M	2.65M	2.74M	2.81M	2.89M	1.35M	1.47M	158.84M	157.8M	27.79M
Total Liabilities	20.41M	18.3M	16.42M	14.86M	21.59M	16.19M	11.44M	6.26M	8.35M	8.23M	8.27M	7.79M	4.96M	6.24M	162.59M	159.33M	29.65M
Total Debt	6.22M	6.32M	6.4M	6.49M	6.5M	6.11M	6.07M	2.59M	2.62M	2.64M	2.67M	2.7M	1.18M	1.17M	1.23M	157.36M	142K
Common Stock	5K	5K	5K	5K	4K	4K	4K	4K	4K	4K	4K	4K	4K	4K	n/a	n/a	n/a
Retained Earnings	-251.31M	-225.74M	-201.72M	-183.02M	-164.83M	-142M	-120.85M	-107.58M	-95.7M	-82.8M	-70.29M	-55.2M	-40.37M	-30.44M	-23.8M	-18.29M	-14.08M
Comprehensive Income	770K	1.75M	-184K	-6K	381K	n/a	0.00	n/a	-0.00	-0.00	-0.00	n/a	0.00	-315.97M	-0.00	0.00	n/a
Shareholders Equity	343.15M	362.29M	376.04M	389.88M	204.26M	222.17M	238.57M	248.79M	-95.7M	267.76M	278.85M	291.18M	301.74M	309.73M	-22.67M	-17.52M	-13.64M
Total Investments	249.47M	256.24M	275.31M	129.1M	146.46M	1M	1M	n/a	1M	1M	1M	1M	243K	243K	n/a	243K	n/a